Point-of-Care Molecular Diagnostics Market is expected to reach US$ 45,381.18 million by 2028

Assays and Kits Segment to Lead Point-of-Care Molecular Diagnostics Market During 2021–2028

According to our latest study on “Point-of-Care Molecular Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product & Services, Technology, Application, and End User,” the market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the point-of-care molecular diagnostics market is primarily attributed to the growing demand for specific viral detection methods that consume less time for timely infection control and rising incidence of infectious diseases. However, pricing pressures owing to reimbursement cut hinder the market growth.

Based on product & services, the point-of-care molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment leads the market and is expected to register the highest CAGR in the market during the forecast period.

bioMérieux SA; F. Hoffmann-La Roche Ltd.; Danaher Corporation; Enzo Biochem, Inc.; Abbott; binx health Inc.; Meridian BioScience, Inc.; Biocartis, Quidel Corporation, and Bio-Rad Laboratories, Inc. are a few leading companies operating in the point-of-care molecular diagnostics market.

Point-of-Care Molecular Diagnostics Market, by Region, 2021 (%)

---

Point of Care Molecular Diagnostics Market Size Analysis To 2028

Download Free Sample

---

Point-of-Care Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product & Services (Assays and Kits, Instruments, and Services and Software), Technology [PCR, Isothermal Nucleic Acid Amplification Technology (INAAT), and Other Technologies], Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), and End User (Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes, and Others) Geography

The report segments point-of-care molecular diagnostics market as follows:

The point-of-care molecular diagnostics market is segmented on the basis of product & services, technology, application, and end user. Based on product & services, the market is segmented into kits, instruments, and services and software. Based on technology, the market is segmented into PCR, isothermal nucleic acid amplification technology (INAAT), and other technologies. Based on application, the point-of-care molecular diagnostics market is segmented into infectious diseases, oncology, hematology, prenatal testing, endocrinology, and other applications. By end user, the market is segmented into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others.

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of APAC
• Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of MEA
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM